A new technique combining virtual simulation and methylene blue staining for the localization of small peripheral pulmonary lesions by Yang Shentu et al.
Shentu et al. BMC Cancer 2014, 14:79
http://www.biomedcentral.com/1471-2407/14/79RESEARCH ARTICLE Open AccessA new technique combining virtual simulation
and methylene blue staining for the localization
of small peripheral pulmonary lesions
Yang Shentu1†, Liang Zhang1,2†, Hengle Gu1, Feng Mao1, Minghui Cai1, Zhengping Ding1 and Zhiqiang Wang3*Abstract
Background: Quickly and accurately localizing small peripheral pulmonary lesions can avoid prolonged operative
time and unplanned open thoracotomy. In this study, we aimed to introduce and evaluate a new technique
combining virtual simulation and methylene blue staining for the localization of small peripheral pulmonary lesions.
Methods: Seventy four (74) patients with 80 peripheral pulmonary lesions <20 mm in size on computer
tomography (CT) were virtually punctured using a radiotherapy planning simulator on the day before operation.
Under general anaesthesia, methylene blue dye was injected to the virtually identified point according to the
surface point, angle and depth previously determined by the simulator. The wedge resection of the marked lesion
was performed under video-assisted thoracoscopic surgery (VATS) and the specimens were sent for immediate
pathologic examination. According to pathology results, appropriate surgical procedures were decided and
undertaken.
Results: The average lesion size was 10.4±3.5 mm (range: 4-17 mm) and the average distance to the pleural surface
was 9.4±4.9 mm. Our preoperative localization procedure was successful in 75 of 80 (94%) lesions. Histological
examination showed 28 benign lesions and 52 lung cancers. The shortest distance between the edges of the stain
and lesion was 5.1±3.1 mm. Localization time was 17.4±2.3 min. All patients with malignant lesions subsequently
underwent lobectomy and systematic lymph node dissection. No complications were observed in all participants.
Conclusions: The novel technique combining the preoperative virtual simulation and methylene blue staining
techniques has a high success rate for localizing small peripheral pulmonary lesions, particularly for those tiny
lesions which are difficult to visualise and palpate during VATS.
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In recent years, the widespread utilization of CT scan-
ning and the increasing awareness of health screening
have resulted in identification of a large number of small
pulmonary lesions. It has been reported that a large
number, about 59% to 73%, of those lesions with a local-
ized area of ground glass opacity nodules are early stage
cancers [1] while some lesions are benign. Generally, the
wedge resection of the nodule is performed first for
pathologic examination, and further treatment planning* Correspondence: z.wang@uq.edu.au
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unless otherwise stated.for small peripheral pulmonary nodules will depend on
pathologic findings to prevent unwanted thoracotomy.
However, the challenge that we often face during the
surgery is to quickly and accurately localize those small
nodules, particularly those tiny nodules which are difficult
to be quickly palpated. Inadequate nodule localization
might lead to a prolonged operative time and even conver-
sion to an unplanned open thoracotomy [2,3]. Therefore,
several preoperative localization techniques have been
introduced as a method of improving the success rate of
video-assisted thoracoscopic surgery (VATS) [4-9]. Each
technique has its strengths and limitations. In this study,
we introduce a novel technique which applies the virtual
simulation, a technique for radiotherapy planning [10,11],Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 CT Scanning to collect data for simulation. Spine (a)
and (b) prone position.
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localization of small peripheral pulmonary nodules. In this
study, we describe this procedure and assess the perform-
ance of this technique in 80 small peripheral pulmonary
lesions from 74 Chinese patients.
Methods
Participants
From February 2012 to February 2013, 74 participants
aged from 29 to 81 years were recruited from Shanghai
Chest Hospital for medical check-ups. All participants
met the following criteria. First, they underwent chest
CT scanning with an identified peripheral pulmonary
lesion <20 mm in diameter in the outer third of the lung
field. Those lesions were not directly visible on the lung
surface. Second, those lesions had not been pathologic-
ally examined before this study so that the diagnosis of
the lesions was unknown. Third, no other overt abnor-
malities were detected in blood routine, blood glucose,
electrolyte and ECG results. They had normal lung, liver,
kidney and blood coagulation functions. Abdominal
ultrasound, brain MRI, and whole body bone scan
showed no signs of metastases in those patients. Partici-
pants with at least one of the following were excluded:
1) lesions >20 mm which could be easily localized, 2) le-
sions located in the middle and inner two thirds of the
lung field where the wedge resection was not feasible, 3)
lesions close to the pleural surface with visible pleural
retraction, 4) impossible to inject methylene blue dye be-
cause the identified lesions were blocked by a large skel-
etal structure such as scapula according to CT scanning
results, and 5) lesions close to heart, large blood vessels,
diaphragm and major nerves with a high risk of injuring
them. Among 74 participants recruited, 80 lesions were
identified. As the probability of finding malignancy
among the participants with lesions was high, all eligible
participants with lesions went through the proposed
localization procedure. This project was approved by the
Ethics Review Committee of Shanghai Chest Hospital
and informed consent was obtained from all partici-
pants, including consent for participation, and consent
to publish findings and to use anonymous images in
medical publications.
Virtual simulation ─ methylene blue staining technique
The virtual simulation ─ methylene blue staining tech-
nique contains preoperative and intraoperative localization
procedures.
Preoperative localization
1) CT scanning: On the day before the operation, a CT
scan was performed in the Department of Radiology
at the Shanghai Chest Hospital using SiemensSOMATOM Sensation 16 (Siemens AG, Medical
Solutions, Germany). Accompanied by one
researcher (LZ), patients were placed on the CT
table in either a spine or prone position which
allowed the shortest access to the targeted lesion.
The spine position (Figure 1a) was suitable for
injecting methylene blue dye from the front or axilla
area while the prone position (Figure 1b) was for
injecting from the back. The targeted lesion was
located with several scans of contiguous 2 mm
section thickness in full inspiration. The researcher
marked the alignment lines of the CT gantry with
a “+” sign, placing a metallic mark.
2) Image transferring and simulation data for virtual
puncturing: The CT images generated in the
Department of Radiology were transferred to the
Department of Radiotherapy in our hospital, in
which an injection plan was developed using the
radiation therapy planning system, Phillips-Pinncle
3 (Philips Healthcare). This system was originally
designed for developing radiation therapy and we
used the various parameters generated from this
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According to the CT images, the system software
calculated the direction and depth of the radiation
beam to the lesion. It also calculated the distance
between skin surface to the lesion and the distance
from the edge of the lesion to the pleural surface.
For our purpose, we envisaged that the injection
needle could act as a beam and follow the direction
of the beam to reach the targeted lesion according
to the distance from skin surface to the lesion
calculated by the system. For each lesion, the system
provided various entry points and angles. We chose
the point with either vertical or horizontal angle
to minimize operational difficulties and errors
(Figure 2). The simulated virtual data for puncturing
were recorded for the next step.
3) Puncture point marking: After obtaining the
above data, we placed the patient on a simulator
(Ximatron series) for radiotherapy planning in
the same position as that for the original CT
scan to perform a full 3 D simulation. To ensure
the same position as that when the data were
collected previously, the alignment lines of the
CT gantry aimed at those three “+” signs.
Guided by those simulation data, through the
computer controlled machine and bed movements,Figure 2 Image generated using radiation therapy planning system bthe puncture point was identified and marked
as “*” (Figure 3 and Figure 4).
4) Injecting methylene blue in the operation room:
Under general anaesthesia, the patient was placed in
the same position as that for preoperative CT image
collection, and 0.3 ml methylene blue was injected at
the marked point according to the angle and depth
data and again another 0.2 ml at 10 mm from
pleural during needle removal to stain the needle
pathway (Figure 5).
Intraoperative localization procedures
Immediately after injecting methylene blue, the skin was
disinfected and thoracoscopy was performed to locate
the stain. The surrounding surface was palpated using
the index finger for the lesion. The wedge resection of
the identified lesion was performed using VATS along
with a 3 cm margin of normal lung tissue, including the
stained area, and the specimen was placed next to a
5 ml syringe which was taken as a reference length scale
to measure the distance between the edge of the lesion
and the edge of the stain (Figure 6). The specimen was
sent for immediate pathologic examination. All patients
with malignant lesions subsequently underwent lobec-
tomy and systematic lymph node dissection. For those
with benign lesions, the surgery was completed.ased on images and data collected from previous CT scan.
Figure 3 Patient on a simulator for radiotherapy planning in
the same position as that for the original CT scan to perform a
full 3 D simulation.
Figure 5 Injection of methylene blue dye to the virtually
identified point under general anaesthesia. a) Spine position
with vertical injection. b) Spine position with horizontal injection.
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The preoperative localization time was defined as the
period from the time start of CT scanning to the time of
marking skin puncture point. Intra-operative localization
time was from the injection of methylene blue to the
time that the stain was located with the thoracoscope.
The success of the localization was determined accord-
ing to the distance between the edge of the stain andFigure 4 Identifying and marking the surface puncture point.that of the lesion (<20 mm). The success proportions
and 95% confidence interval were calculated. Linear
regression models were used to assess if age, gender,
and the location, distance from pleural surface and
size of lesions were associated with the accuracy of
this technique. All analyses were performed with Stata
SE 12 [12].
Results
Characteristics of participants and lesions
Table 1 shows the characteristics of 74 study participants
(27 men and 47 women) and 80 lesions. About 31%
study participants were smokers. Two cases had pre-
viously been diagnosed with a malignant tumor: one
underwent surgery for rectal cancer two years after the
identification of the current lesion and the other had
been received surgery for thyroid cancer three years
before. The mean lesion size was 10.4 mm (SD: 3.5),
ranging from 4 mm to 17 mm. The mean intra-operative
localization time was 17.4 (SD: 2.3) minutes, ranging
from 12 to 23 minutes.
Figure 6 A lesion on right lower lobe. a) CT Image, b) Thoracoscopic
view, and c) Specimen of wedge resection.
Table 1 Characteristics of 74 study participants and 80
peripheral pulmonary lesions
Characteristics Mean (SD)
Age, years 55.1 (10.7)
Male, n (%) 35 (37.5)
Smoker, n (%) 23 (31.1)
History of prior malignancy 2 (2.7)
Family history of malignancy 3 (4.1)
Diameter, mm 10.4 (3.5)
Distance from lesion to the pleural surface, mm 9.4 (4.9)
Preoperative localization time, minutes 22.2 (5.0)
Intraoperative localization time, minutes 17.4 (2.3)
Stain – lesion distance, mm 5.1 (3.1)
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staining technique
Seventy five of 80 lesions were successfully localized and
the successful localization rate was 94% (95% CI: 86, 98).
The stain-lesion distance for those successfully localized
lesions was 5.3 (SD: 3.1), ranging from 0 to 12 mm.
Histological examination showed 28 benign lesions and
52 lung cancers.Table 2 shows the stain-lesion distances and successful
localization rates by location and pathological diagnosis.
There was no significant difference in stain-lesion dis-
tance between left and right lungs. The stain-lesion dis-
tances were not dependent on the type of histological
diagnosis, lesion sizes, age and sex. The lower lobes had
a significantly longer stain-lesion distance than upper
and middle lobes with a crude average of 3.0 (95% CI:
1.6, 4.3) mm (p<0.001). Further controlling for age, sex,
lesion size and pathological diagnosis using the multiple
linear regression method, the adjusted difference be-
tween lower and upper/middle lobes in stain-lesion
distance remained statistically significant with a mean of
3.0 (95% CI: 1.7, 4.4), p<0.001. However, about 80%
stain-lesion distances were<5 mm for lesions on middle/
upper lobes while 80% stain-lesion distances were
<10 mm for lesions on the lower lobes (Figure 7). The
successful localization rate was 98% (95% CI: 90, 100)
for lesions in upper or middle lobes, which was signifi-
cantly higher than that for lesions in lower lobes (86%),
p=0.036. There were no significant differences in the
successful localization rate or stain-lesion difference
between left and right lungs and between benign and
malignant lesions.
All patients with successfully localized malignant
lesions subsequently underwent lobectomy via VATS
and systematic lymph node dissection. The postoperative
pathology examination revealed all cancer cases as stage
T1aN0M0. Wedge resection was performed to remove
benign lesions. There were no complications observed in
any of the patients as a result of the localization. Among
five unsuccessful localized lesions, four were later local-
ized through thorough index palpation around 20-23 mm
from the stain. Only one lesion was not localized and the
patient underwent thoracotomy. Since the pathologic
examination confirmed as a lung cancer case, this patient
underwent lobectomy by thoracotomy.
Table 2 Stain – nodule distance and successful
localization rates by different characteristics




Mean (SD) P Rate (95% CI) P
Left vs right lobes
Left 28 5.1 (2.9) 93 (76, 99)
Right 52 5.0 (3.2) 0.90 94 (84, 99) 0.81
Upper/middle vs lower
Upper/Middle 51 4.1 (2.4) 98 (90, 100)
Lower 29 7.0 (3.4) <0.001 86 (68, 96) 0.036
Diagnosis
Benign 28 5.4 (2.8) 96 (82, 100)
Malignant 52 4.9 (3.3) 0.46 92 (81, 98) 0.47
Lesion size
≤10 mm 42 4.9 (2.7) 93 (81, 99)
>10 mm 38 5.2 (3.5) 0.76 95 (82, 99) 0.73
Lesion to pleural
distance, mm
<10 mm 39 5.1 (2.8) 95 (83, 99)
≥10 mm 41 5.0 (3.4) 0.82 93 (80, 98) 0.69
Age
<55 years 35 5.1 (3.0) 95 (82, 99)
≥55 years 40 5.0 (3.2) 0.87 93 (81, 99) 0.77
Sex
Male 29 5.9 (2.6) 97 (83, 100)
Female 46 4.6 (3.3) 0.074 92 (81, 98) 0.20
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In this study, we demonstrated that a new technique
could be used to successfully localize small peripheral
pulmonary lesions. We found this technique performed






















Figure 7 Cumulative distributions of stain-lesion distance for
lesions on middle/upper versus those on lower lobes.and distance from lesion to the pleural surface, and
patient’s age and gender. This technique performed sig-
nificantly better for the lesions in upper lobes than in
lower lobes. This technique combines the existing virtual
simulation technique for planning radiotherapy and
methylene blue staining.
With the increasing application of CT to lung cancer
screening, small lesions are frequently detected [13,14].
However, for small lesions, localizing them visually or by
palpation during VATS can be difficult [5,6]. To shorten
the time for nodule localization and to prevent unplanned
open thoracotomy, several preoperative localization tech-
niques have been introduced as a method of improving
the success rate of VATS. Punkett et al. developed a tech-
nique of hookwire localization with CT guidance [15-17].
This approach has a high successful localization rate, but
increases the risk of some complications including
pneumothorax, pleuritic pain, and haemorrhage [18]. It is
also associated with a relatively high level of radiation for
both patients and doctors. The VATS should be per-
formed immediately after the hookwire placement, which
may cause operational difficulties in a busy hospital like
ours. Lenglinger et al. developed the percutaneous staining
with methylene blue method [8]. Guided by CT, methy-
lene blue dye is injected into the nodule. This method also
has a high successful localization rate and no complica-
tions associated with the previously mentioned hookwire
placement [8,19,20]. However, the operation should be
performed immediately after the injection before the dye
is diffused. To overcome this problem, Nomori and Horio
developed a long-lasting point marker termed “colored
collagen” which combining atelocollagen, methylene blue
and contrast medium [21]. The colored collagen stayed
visible at the injected site for several days without toxicity.
Another marking technique called “agar marking” was de-
veloped by Tsuchida et al. [22]. Powdered agar dissolved in
distilled water and kept at >50 degree Celsius to maintain
its liquid form which is injected to the target lesion guided
by CT. Then, agar can be detected as a hard nodule by
palpation, but this approach is difficult to implement.
Shennib et al. reported the use of intraoperative intra-
thoracic ultrasonography for localization of small lesions
during VATS [23], which has been assessed by others as a
non-invasive and easy to operate technique [24,25]. How-
ever, this technique does not perform well for small
lesions <10 mm, particularly for ground glass pulmonary
nodules. It also does not perform well for patients with
asthma or chronic obstructive pulmonary disease because
of the influence of air in the lung tissue. Recently,
Chen et al. reported an image-guided navigation system
for localization of small pulmonary nodules before thora-
coscopic surgery [26]. Although this technique can suc-
cessfully localize the nodules without some shortcomings
of other techniques, the system is costly and complex to
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clinical settings.
In our study, we introduced a new technique combin-
ing the existing virtual simulation for radiotherapy plan-
ning technique and methylene blue staining for the
localization of small peripheral pulmonary lesions. With
a successful localization rate of 94%, this technique has
the following advantages. First, the doctors are not ex-
posed to radiation during the preoperative localization
period, and the patients are only exposed to radiation
during the initial CT image collection. Second, the
patients do not need to be sent to the operating room
immediately after virtual puncture, which allows suffi-
cient time for preoperative preparation. Third, patients
are less stressed when methylene blue dye was injected
under general anaesthesia. Forth, since the injection is
performed under general anaesthesia, complications
such as pneumothorax and haemorrhage are rare and
can be relatively easily handled. Fifth, the operation is
performed immediately after the methylene blue injec-
tion with little time for the dye to diffuse around the
tissue. Finally, since the virtual puncture can be per-
formed using equipment commonly available, it can be
easily adopted by most hospitals without extra cost for
new equipment. The special equipment required for this
technique is a CT simulator (radiation therapy planning
system), which is generally available in most hospitals
with facilities for radiation therapy. The cost of methy-
lene blue dye is minimal and the total cost of the whole
procedure is equivalent to that of a chest CT scan.
However, there are some limitations. First, unlike the
real-time CT guided localization methods, the accuracy
of our technique depends on the similarity between the
body position for virtual puncture and that for injecting
the dye. Any inconsistency may cause deviation from the
targeted lesion, particularly for the cases in which injec-
tion needs to be performed from the back. At the early
stage of the study, we instructed patients to cross their
hands on the back of the head in a prone position during
virtual puncture. Such a position is difficult to repeat
during the injection when patients are under general
anaesthesia. To minimize such deviation, during the
simulation puncture, we instructed patients to naturally
rest their hands to their thighs to imitate a position as
the one when they were under general anaesthesia for
the dye injection. Second, if the injection path is blocked
by a costa, the needle entry point should be moved up-
ward or downward and the needle angle will also be
changed. This may also cause an inaccurate staining point.
Our data showed that the technique performed much bet-
ter for lesions in the upper and middle lobes than those in
the lower lobes. The poor performance for localizing
lesions in the lower lobe could be partly explained by
those limitations. Our technique failed to localize five ofthe 80 lesions, three of them were due to inconsistent
body positions between simulation and actual injection as
previously described, one was due to the lesion being close
to the pleural surface and one due to too much dye being
injected causing wide diffusion around the tissue. Further
investigation is needed to improve the performance of this
technique for localizing small peripheral lesions, particu-
larly those in the lower lobes.
From our clinical experience of successful localization,
it is important to keep the same body position for the
dye injection as that during the simulation. If possible, a
horizontal or vertical injection angle should be adopted
to inject approximately 0.3 ml of methylene blue dye
into the target lesion site and again about 0.2 ml into
about 10 mm from the pleural surface during the removal
of the needle. Too much dye should be avoided to prevent
a large stained area.
Conclusions
Applying CT simulation technique to virtually localize
small peripheral lesions and injecting methylene blue dye
to the target point according to the simulated data can lead
to a high successful localization rate. This technique does
not require new equipment and the patients have lower
exposure to radiation compared to using a real-time CT
guided approach. Injection of the methylene blue dye
under general anaesthesia minimises patients stress and as-
sociated complications. This technique is safe, effective and
readily acceptable with an overall successful localization
rate of 94%, even higher for those lesions in middle and
upper lobes (98%). Further efforts are needed to improve
the successful localization rate and minimize errors.
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